Papillomavirus-Induced Oncogenesis: Bridging Molecular Mechanisms, Diagnostics, and Global Prevention Strategies
- PMID: 40284958
- PMCID: PMC12030807
- DOI: 10.3390/v17040515
Papillomavirus-Induced Oncogenesis: Bridging Molecular Mechanisms, Diagnostics, and Global Prevention Strategies
Abstract
Human papillomavirus (HPV) has long been recognized for causing benign lesions such as warts, but its pivotal role in cancer was established in the late 20th century, culminating in the 2008 Nobel Prize awarded to Harald zur Hausen for linking HPV to cervical cancer [...].
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Development of a quality framework for models of cervical screening and its application to evaluations of the cost-effectiveness of HPV vaccination in developed countries.Vaccine. 2015 Jan 1;33(1):34-51. doi: 10.1016/j.vaccine.2014.08.048. Epub 2014 Aug 27. Vaccine. 2015. PMID: 25171843
-
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3. Cochrane Database Syst Rev. 2018. PMID: 29740819 Free PMC article.
-
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD008054. doi: 10.1002/14651858.CD008054.pub2. Cochrane Database Syst Rev. 2013. PMID: 23543559 Free PMC article.
-
Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer.Clin Infect Dis. 2017 May 1;64(9):1228-1235. doi: 10.1093/cid/cix135. Clin Infect Dis. 2017. PMID: 28199532 Free PMC article.
-
The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women.Gynecol Obstet Invest. 2025;90(2):143-152. doi: 10.1159/000541641. Epub 2024 Oct 7. Gynecol Obstet Invest. 2025. PMID: 39374596 Free PMC article.